Testing a reduced-dose diphtheria-tetanus-pertussis vaccine
Part of Infections, Lungs & breathing clinical trials.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 6 years old or older.
- You cannot have received any other vaccine within the past 30 days or plan to get one within 30 days after the study vaccine.
- You must not have a current illness like fever or a flare-up of a chronic condition.
- You cannot have had close contact with someone who has whooping cough, diphtheria, or tetanus in the past month.
- You should not have a history of serious allergic reactions to vaccine components, or certain medical conditions like epilepsy, bleeding disorders, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.
This study is checking how long the protection from an earlier vaccine (which combined protection against whooping cough, diphtheria, and tetanus) lasts. If you took part in that earlier trial, this follow-up will help see if you still have protection.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
This study checks on people who got a single dose of a whooping cough vaccine about 10 years ago in a previous study. Researchers want to see how well the vaccine is still working and if it is still safe.
This study tests whether giving pregnant women a special tetanus, diphtheria, and pertussis vaccine (TdaP2gen) helps protect their babies from these diseases. Researchers will follow mothers and infants for up to 18 months to measure how well the vaccine works.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.